May 26 2023 18 mins
The US Food and Drug Administration Guidance for Industry #263, or GFI 263, goes into effect nationally in the US in early June 2023. The new mandate changes the approved marketing status of certain antimicrobial drugs from over the counter to prescription status. Drugs that were commonly found on retail shelves and through online sources will no longer be available for purchase by the public and will only be accessible by veterinarian prescription.
In this episode, Dr. Michael Costin, Associate Director in the Division of Animal and Public Health at the American Veterinary Medical Association (AVMA), explains the background and reason for GFI 263's enactment. Dr. Costin also talks about how it impacts not only the veterinary profession but also consumers who raise, breed and care for companion and large animals. Dr. Joanne Carlson, ISVMA President, hosts the conversation.